Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 6/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | HTR3A | P46098 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.36 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | GLRA1 | P23415 | 2/20 | 0.36 |
| ▸ | GLRB | P48167 | 2/20 | 0.36 |
| ▸ | SCN1A | P35498 | 1/20 | 0.36 |
| ▸ | TAS2R46 | P59540 | 1/20 | 0.36 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.36 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.36 |
| ▸ | TAS2R10 | Q9NYW0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29352385 | 0.86 | CHRNA7 (0.44) | CHRNA7MEN1KMT2ATDP1CHRM2 | |
| Isostrychnine SCHEMBL29898321 | 0.68 | CHRNA7 (0.43) | CHRNA7MEN1KMT2ACHRM2CHRNA4 | |
| Hydrochloric Acid SCHEMBL31650965 | 0.64 | CHRNA7 (1.00) | CHRNA7CHRM2CHRNA4KCNH2HTR3A | |
| Vinervine SCHEMBL30046744 | 0.62 | MEN1 (0.74) | MEN1KMT2ATDP1OPRM1OPRK1 | |
| SCHEMBL31150554 | 0.62 | MEN1 (1.00) | MEN1KMT2ATDP1OPRM1OPRK1 | |
| Alcuronium SCHEMBL30817419 | 0.60 | CHRNA7 (0.98) | CHRNA7CHRM2CHRNA4KCNH2HTR3A | |
| Akuammicine SCHEMBL29517606 | 0.59 | MEN1 (0.69) | MEN1KMT2ATDP1OPRM1OPRK1 | |
| SCHEMBL8053306 | 0.48 | OPRL1 (0.61) | OPRM1OPRK1OPRD1 | |
| SCHEMBL6334445 | 0.46 | NOTUM (0.42) | MEN1KMT2AOPRM1OPRK1OPRD1 | |
| SCHEMBL13068280 | 0.46 | AKT1 (0.49) | OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025111447-A1 | TREATMENT OF CANCER WITH DRUG COMBINATIONS | FLORIDA ATLANTIC UNIVERSITY BOARD OF TRUSTEES (US) | 2025-05-30 | — | — | WO | claimed |
| US-20240180891-A1 | SYNERGISTIC MODULATORS OF ALPHA-DICARBONYL DETOXIFICATION AND THEIR USE FOR INDUCING WEIGHT LOSS AND THE TREATMENT OF DIABETIC PATHOLOGIES | BUCK INSTITUTE FOR RESEARCH ON AGING (US) | 2024-06-06 | — | — | US | claimed |
| CN-115448969-A | Refining method of desogestrel | 上海格苓凯生物科技有限公司 | 2022-12-09 | — | — | CN | claimed |
| WO-2022140279-A1 | SYNERGISTIC MODULATORS OF ALPHA-DICARBONYL DETOXIFICATION AND THEIR USE FOR INDUCING WEIGHT LOSS AND THE TREATMENT OF DIABETIC PATHOLOGIES | BUCK INSTITUTE FOR RESEARCH ON AGING (US) | 2022-06-30 | — | — | WO | claimed |
| CN-113599402-B | Semen Platycladi or semen Platycladi extract and application thereof | 中国科学院上海药物研究所 | 2022-06-28 | — | — | CN | claimed |
| US-20260068922-A1 | LIQUID COMPOSITION FOR AN ELECTRONIC VAPOR DEVICE | CRONOS GROUP INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20250376488-A1 | FARNESOID X RECEPTOR MODULATORS | INTERCEPT PHARMACEUTICALS INC (US) | 2025-12-11 | — | — | US | disclosed |
| US-20250283122-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2025-09-11 | — | — | US | disclosed |
| US-12379386-B2 | Antibodies to 25-hydroxyvitamin D2 and D3 for detecting total 25-hydroxyvitamin D | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2025-08-05 | — | — | US | disclosed |
| US-20250207142-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2025-06-26 | — | — | US | disclosed |
| WO-2025111447-A1 | TREATMENT OF CANCER WITH DRUG COMBINATIONS | FLORIDA ATLANTIC UNIVERSITY BOARD OF TRUSTEES (US) | 2025-05-30 | — | — | WO | disclosed |
| US-20250145659-A1 | SYNTHESIS OF CHOLESTEROL FORM BISNORALCOHOL | FERMENTA BIOTECH LIMITED (IN) | 2025-05-08 | — | — | US | disclosed |
| CN-113599402-B | Semen Platycladi or semen Platycladi extract and application thereof | 中国科学院上海药物研究所 | 2022-06-28 | — | — | CN | disclosed |
| US-20220195472-A1 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | GINKGO BIOWORKS, INC. (US) | 2022-06-23 | — | — | US | disclosed |
| US-11345721-B2 | TGR5 modulators and methods of use thereof | INTERCEPT PHARMACEUTICALS, INC. (US) | 2022-05-31 | — | — | US | disclosed |
| US-20220151948-A1 | Treating Vasculature Related Diseases or Disorders Using Nanoparticles | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-05-19 | — | — | US | disclosed |
| WO-2022074965-A1 | FILAMENT, MATERIAL, AND MATERIAL MANUFACTURING METHOD | 三菱瓦斯化学株式会社 | 2022-04-14 | — | — | WO | disclosed |
| EP-3981779-A1 | FARNESOID X RECEPTOR MODULATORS | Intercept Pharmaceuticals, Inc. (US) | 2022-04-13 | — | — | EP | disclosed |
| US-11274320-B2 | Biosynthesis of cannabinoids and cannabinoid precursors | GINKGO BIOWORKS, INC. (US) | 2022-03-15 | — | — | US | disclosed |
| US-11241394-B2 | Treating vasculature related diseases or disorders using nanoparticles | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12379386-B2 | Antibodies to 25-hydroxyvitamin D2 and D3 for detecting total 25-hydroxyvitamin D | VDR, GC, CYP24A1 | CHRNA7 4387/4885MEN1 1998/4885KMT2A 4123/4885 |
| US-11345721-B2 | TGR5 modulators and methods of use thereof | GPBAR1, TAAR5, LPAR5 | CHRNA7 3363/4885MEN1 3310/4885KMT2A 3147/4885 |
| US-20260068922-A1 | LIQUID COMPOSITION FOR AN ELECTRONIC VAPOR DEVICE | CNR2, CNR1, TRPV1 | CHRNA7 207/4885MEN1 4191/4885KMT2A 2722/4885 |
| US-20240180891-A1 | SYNERGISTIC MODULATORS OF ALPHA-DICARBONYL DETOXIFICATION AND THEIR USE FOR INDUCING WEIGHT LOSS AND THE TREATMENT OF DIABETIC PATHOLOGIES | PDXK, PLPBP, GLS | CHRNA7 2462/4885MEN1 3773/4885KMT2A 1599/4885 |
| US-20250145659-A1 | SYNTHESIS OF CHOLESTEROL FORM BISNORALCOHOL | HMGCR, DHCR7, CYP46A1 | CHRNA7 350/4885MEN1 2116/4885KMT2A 2805/4885 |
| US-20250376488-A1 | FARNESOID X RECEPTOR MODULATORS | NR1H4, SLC10A1, GPBAR1 | CHRNA7 1030/4885MEN1 1113/4885KMT2A 4219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.